Carole Huntsman

Executive Vice President and Chief Commercial OfficeratMadrigal Pharmaceuticals· In proxies 2023–2025

Pay in FY2025+38% from the year before · Madrigal Pharmaceuticals stock +88.7% the same year

Carole Huntsman was paid $5.4M in FY2025 (Dec), up 38%. Madrigal Pharmaceuticals stock rose 88.7% that year.

Pay$100 in the stock at the end of FY22 → $201

Pay is from the Summary Compensation Table of each Madrigal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

MDGL
Madrigal PharmaceuticalsPublic company · 3 yr
- Executive Vice President and Chief Commercial Officer2023 – Present · 3 yrStock in role +65%

Roles come from the proxy statements of each company.

Activity

Pay
Madrigal Pharmaceuticals Division head pay rose 38% to $5.4M. The stock rose 89% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Madrigal Pharmaceuticals Division head pay rose 26% to $3.9M. The stock rose 33% in FY2024 (Dec).
DEF 14AApr 29, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?